City

Chuncheon (1)

Daegu (1)

Seoul (1)

Condition

Crescentic Glomerulonephritis (2)

ANCA Associated Vasculitis (1)

Focal Segmental Glomerulosclerosis (1)

Glomerular Disease (1)

IgA Nephropathy (1)

Lupus Nephritis (1)

Membranous Nephropathy (1)

Minimal Change Disease (1)

Rapidly Progressive Glomerulonephritis (1)

Overall Status

Not yet recruiting (1)

Recruiting (1)

Phase

phase 3 (1)

Sponsor

Assistance Publique - Hopitaux de Paris (1)

Seoul National University Hospital (1)

Collaborator

Chung-Ang University Hosptial, Chung-Ang University College of Medicine (1)

KangWon National University Hospital (1)

Keimyung University Dongsan Medical Center (1)

Ministry of Health & Welfare, Korea (1)

Ministry of Health, France (1)

SMG-SNU Boramae Medical Center (1)

Seoul National University Bundang Hospital (1)

Severance Hospital (1)

Intervention

kidney biopsy (1)

pioglitazone (actos®) (1)

placebo of pioglitazone (1)

Study Documents

Intervention Type

drug (1)

other (1)

Funder Type

Other (2)

Study Type

Interventional (1)

Observational [Patient Registry] (1)

crescentic glomerulonephritis

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

ANCA Associated Vasculitis, Rapidly Progressive Glomerulonephritis, Crescentic Glomerulonephritis Trial (Pioglitazone (ACTOS®),

Not yet recruiting

ANCA Associated Vasculitis
+2 more

Pioglitazone (ACTOS®)
Placebo of Pioglitazone

(no location specified)

Jul 7, 2023

Glomerular Disease, Minimal Change Disease, IgA Nephropathy Trial in Chuncheon, Daegu, Seoul (Kidney Biopsy)

Recruiting

Glomerular Disease
+6 more

Kidney Biopsy

Chuncheon, Korea, Republic of
+5 more

Feb 10, 2020